Bergen's BOB Creates a Med/Surg Formulary
Executive SummaryBergen Brunswig's hospital supply business has launched a preferred supplier program to help alternate site and some hospital customers lower costs through "focused, strategic" relationships. Such programs are gaining ground in the hospital supply business, but they raise issues--about the relationship of distributors to GPOs and distributors to manufacturers--that distributors may find vexing.
You may also be interested in...
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.